{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004395.5:c.3853G>C",
          "cDNA Change": {
            "transcript": "NM_004395.5",
            "ref": "G",
            "alt": "C",
            "position": "3853"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "1285"
          },
          "Description in input context": "E1285A variant (c.3853G>C) associated with increased kinase activity in Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0019483"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Stable HEK293 cell lines expressing wild-type and E1285A LRRK2 variants were used"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004395.5:c.3853G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E1285A variant showed 2.3-fold increase in phosphorylation of MAPT compared to wild-type (p<0.01)"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed"
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2-expressing cells used as positive control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells used as negative control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed Student's t-test with Bonferroni correction"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 20% of wild-type control",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels > 50% above wild-type control",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Drosophila melanogaster",
        "Description": "Drosophila models expressing E1285A LRRK2 were analyzed for dopaminergic neuron degeneration"
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004395.5:c.3853G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "neurodegenerative effect",
          "Result Description": "E1285A-expressing flies showed 40% reduction in dopaminergic neuron count compared to controls (p<0.001)"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five independent fly lines analyzed"
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type fly brains used as positive control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-transgenic flies used as negative control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Kruskal-Wallis test with Dunn's post-hoc analysis"
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Dopaminergic neuron count > 80% of wild-type",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Dopaminergic neuron count < 60% of wild-type",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}